Exact Mass: 321.9623

Exact Mass Matches: 321.9623

Found 61 metabolites which its exact mass value is equals to given mass value 321.9623, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Minodronic acid

Minodronic acid

C9H12N2O7P2 (322.012)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2].

   

Minodronic acid

(1-Hydroxy-2-(imidazo(1,2-a)-pyridin-3-yl)ethylidene)bisphosphonic acid monohydrate

C9H12N2O7P2 (322.012)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2].

   
   
   

2-[(4-bromo-1,3-thiazol-2-yl)methyl]isoindole-1,3-dione

2-[(4-bromo-1,3-thiazol-2-yl)methyl]isoindole-1,3-dione

C12H7BrN2O2S (321.9412)


   

methyl 3-bromo-6-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

methyl 3-bromo-6-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

C10H6BrF3N2O2 (321.9565)


   

N-BOC-2-AMINO-5-BROMOTHIAZOLE-4-CARBOXYLIC ACID

N-BOC-2-AMINO-5-BROMOTHIAZOLE-4-CARBOXYLIC ACID

C9H11BrN2O4S (321.9623)


   

1-bromo-4-(1,1,2,3,3,3-hexafluoropropoxy)benzene

1-bromo-4-(1,1,2,3,3,3-hexafluoropropoxy)benzene

C9H5BrF6O (321.9428)


   

Benzene,2,3-bis(bromomethyl)-1,4-dimethoxy-

Benzene,2,3-bis(bromomethyl)-1,4-dimethoxy-

C10H12Br2O2 (321.9204)


   

2-(5-BROMO-2-CHLORO-PHENYL)-BENZOOXAZOL-5-YLAMINE

2-(5-BROMO-2-CHLORO-PHENYL)-BENZOOXAZOL-5-YLAMINE

C13H8BrClN2O (321.9508)


   

Methyl 4-acetoxy-6-bromo-2-naphthoate

Methyl 4-acetoxy-6-bromo-2-naphthoate

C14H11BrO4 (321.9841)


   

1-(1-PIPERIDINO)CYCLOHEXENE

1-(1-PIPERIDINO)CYCLOHEXENE

C10H8Cl2N2O4S (321.9582)


   

4-CHLORO-3-((3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)OXY)ANILINE

4-CHLORO-3-((3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)OXY)ANILINE

C12H7Cl2F3N2O (321.9888)


   

4-bromo-2-(3-hydroxypropyl)-6-(trifluoromethyl)benzimidazole

4-bromo-2-(3-hydroxypropyl)-6-(trifluoromethyl)benzimidazole

C11H10BrF3N2O (321.9929)


   

2-Phospho-L-ascorbic acid trisodium salt

2-Phospho-L-ascorbic acid trisodium salt

C6H6Na3O9P (321.9443)


L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) is a long-acting vitamin C derivative that can stimulate collagen formation and expression[1]. L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation[2][3].

   

4,4-CARBONYLBIS(PHTHALIC ANHYDRIDE)

4,4-CARBONYLBIS(PHTHALIC ANHYDRIDE)

C17H6O7 (322.0114)


   

Dichlorosulfophenyl-3-methylpyrazolone

Dichlorosulfophenyl-3-methylpyrazolone

C10H8Cl2N2O4S (321.9582)


   

Nickel(2+) sulfamate hydrate (1:2:4)

Nickel(2+) sulfamate hydrate (1:2:4)

H12N2NiO10S2 (321.9287)


   

hexafluoroisopropyl tosylate

hexafluoroisopropyl tosylate

C10H8F6O3S (322.0098)


   

5-(BENZYLOXY)-4-BROMO-2-NITROANILINE

5-(BENZYLOXY)-4-BROMO-2-NITROANILINE

C13H11BrN2O3 (321.9953)


   

4-(4-Bromophenyl)dibenzo[b,d]furan

4-(4-Bromophenyl)dibenzo[b,d]furan

C18H11BrO (321.9993)


   

1,2-bis(bromomethyl)-4,5-dimethoxybenzene

1,2-bis(bromomethyl)-4,5-dimethoxybenzene

C10H12Br2O2 (321.9204)


   

3-CHLORO-4-{[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]OXY}ANILINE

3-CHLORO-4-{[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]OXY}ANILINE

C12H7Cl2F3N2O (321.9888)


   

5-(Phenylsulfonyl)thiophene-2-sulfonyl chloride

5-(Phenylsulfonyl)thiophene-2-sulfonyl chloride

C10H7ClO4S3 (321.9195)


   

3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)THIOPHENE-2-CARBOXYLIC ACID

3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)THIOPHENE-2-CARBOXYLIC ACID

C9H7ClN2O5S2 (321.9485)


   

4-(iodomethyl)-9H-xanthene

4-(iodomethyl)-9H-xanthene

C14H11IO (321.9855)


   

4-(benzenesulfonyl)thiophene-2-sulfonyl chloride

4-(benzenesulfonyl)thiophene-2-sulfonyl chloride

C10H7ClO4S3 (321.9195)


   

2(4-BROMOPHENYL)-2,4,6-TRIHYDROXYACETOPHENONE

2(4-BROMOPHENYL)-2,4,6-TRIHYDROXYACETOPHENONE

C14H11BrO4 (321.9841)


   

ETHANONE, 2-(4-IODOPHENYL)-1-PHENYL-

ETHANONE, 2-(4-IODOPHENYL)-1-PHENYL-

C14H11IO (321.9855)


   

(Diacetoxyiodo)benzene

(Diacetoxyiodo)benzene

C10H11IO4 (321.9702)


   

4,5-DICHLORO-2-(2,6-DICHLOROBENZYL)-2,3-DIHYDROPYRIDAZIN-3-ONE

4,5-DICHLORO-2-(2,6-DICHLOROBENZYL)-2,3-DIHYDROPYRIDAZIN-3-ONE

C11H6Cl4N2O (321.9234)


   

2-bromo-1-(4-chlorophenyl)-2-(4-methylphenyl)ethanone

2-bromo-1-(4-chlorophenyl)-2-(4-methylphenyl)ethanone

C15H12BrClO (321.976)


   

Methyl 2-iodo-4,5-dimethoxybenzoate

Methyl 2-iodo-4,5-dimethoxybenzoate

C10H11IO4 (321.9702)


   
   

Methyl 5-iodo-2,4-dimethoxybenzoate

Methyl 5-iodo-2,4-dimethoxybenzoate

C10H11IO4 (321.9702)


   

ETHYL 3-[5-(CHLOROSULFONYL)-2-THIENYL]-1,2,4-OXADIAZOLE-5-CARBOXYLATE

ETHYL 3-[5-(CHLOROSULFONYL)-2-THIENYL]-1,2,4-OXADIAZOLE-5-CARBOXYLATE

C9H7ClN2O5S2 (321.9485)


   

nickel(ii) amidosulfate tetrahydrate

nickel(ii) amidosulfate tetrahydrate

H12N2NiO10S2 (321.9287)


   

5-Bromouridine

5-Bromouridine

C9H11BrN2O6 (321.98)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents 5-Bromouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

4-bromo-6-phenyldibenzo[b,d]furan

4-bromo-6-phenyldibenzo[b,d]furan

C18H11BrO (321.9993)


   

N-(3,4-Dichlorophenyl)-P-methyl-N-(trifluoromethyl)phosphonamidic acid methyl ester

N-(3,4-Dichlorophenyl)-P-methyl-N-(trifluoromethyl)phosphonamidic acid methyl ester

C9H10Cl2F3NO2P (321.9778)


   

2-(2-iodo-4,5-dimethoxy-phenyl)acetic acid

2-(2-iodo-4,5-dimethoxy-phenyl)acetic acid

C10H11IO4 (321.9702)


   

5-[[(7-CHLORO-4-QUINOLINYL)SULFANYL]METHYL]-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

5-[[(7-CHLORO-4-QUINOLINYL)SULFANYL]METHYL]-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

C13H11ClN4S2 (322.0114)


   

2-[(2-bromo-1,3-thiazol-5-yl)methyl]isoindole-1,3-dione

2-[(2-bromo-1,3-thiazol-5-yl)methyl]isoindole-1,3-dione

C12H7BrN2O2S (321.9412)


   

2-Bromo-1-(1-pyrenyl)ethanone

2-Bromo-1-(1-pyrenyl)ethanone

C18H11BrO (321.9993)


   

3-[(4-Bromophenyl)methoxy]-6-methyl-2-nitropyridine

3-[(4-Bromophenyl)methoxy]-6-methyl-2-nitropyridine

C13H11BrN2O3 (321.9953)


   

5-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]-4-ethyl-4H-1,2,4-triazole-3-thiol

5-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]-4-ethyl-4H-1,2,4-triazole-3-thiol

C13H11ClN4S2 (322.0114)


   

N,N-diethylcarbamodithioic acid (2,2,2-trichloro-1-formamidoethyl) ester

N,N-diethylcarbamodithioic acid (2,2,2-trichloro-1-formamidoethyl) ester

C8H13Cl3N2OS2 (321.9535)


   

1,3-Bis(bromomethyl)-2,5-dimethoxybenzene

1,3-Bis(bromomethyl)-2,5-dimethoxybenzene

C10H12Br2O2 (321.9204)


   

p-Mercuribenzoate

p-Mercuribenzoate

C7H4HgO2- (321.9918)


D010575 - Pesticides > D005659 - Fungicides, Industrial > D010663 - Phenylmercury Compounds D004791 - Enzyme Inhibitors > D008626 - Mercuribenzoates

   

4-chloro-N-(4-chloro-2,5-dimethoxyphenyl)-5-dithiazolimine

4-chloro-N-(4-chloro-2,5-dimethoxyphenyl)-5-dithiazolimine

C10H8Cl2N2O2S2 (321.9404)


   

4-[(5-Bromo-8-quinolinyl)amino]-4-oxobutanoic acid

4-[(5-Bromo-8-quinolinyl)amino]-4-oxobutanoic acid

C13H11BrN2O3 (321.9953)


   

(4-Hydroxy-5-iodo-3-nitrophenyl)acetate

(4-Hydroxy-5-iodo-3-nitrophenyl)acetate

C8H5INO5- (321.9212)


   

2,5,6-Trichloro-1-(beta-D-erythrofuranosyl)benzimidazole

2,5,6-Trichloro-1-(beta-D-erythrofuranosyl)benzimidazole

C11H9Cl3N2O3 (321.9679)


   

α-D-Glucose-1-phosphate (disodium hydrate)

α-D-Glucose-1-phosphate (disodium hydrate)

C6H13Na2O10P (322.0042)


α-D-Glucose-1-phosphate disodium hydrate is used as a starting material for synthesis of glucuronic acid. α-D-Glucose-1-phosphate disodium hydrate can be used as a cytostatic compound essential for cardiopathic therapy, as an antibiotic, as an immunosuppressive agent, and as a circulatory system therapy element[1].

   

(5s)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-hydroxy-5-methylfuran-2-one

(5s)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-hydroxy-5-methylfuran-2-one

C12H16BrClO3 (321.9971)


   

4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-hydroxy-5-methylfuran-2-one

4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-hydroxy-5-methylfuran-2-one

C12H16BrClO3 (321.9971)


   

(5s)-4-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-5-hydroxy-5-methylfuran-2-one

(5s)-4-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-5-hydroxy-5-methylfuran-2-one

C12H16BrClO3 (321.9971)


   

7-bromo-9,10-dihydrophenanthrene-2,3,5,6-tetrol

7-bromo-9,10-dihydrophenanthrene-2,3,5,6-tetrol

C14H11BrO4 (321.9841)


   

(5s)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-hydroxy-5-methylfuran-2-one

(5s)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-hydroxy-5-methylfuran-2-one

C12H16BrClO3 (321.9971)